Total Payments
$3,326
2024 Payments
$622.25
Companies
20
Transactions
137
Medicare Patients
803
Medicare Billing
$123,945
Payment Breakdown by Category
Food & Beverage$3,326 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,326 | 137 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $1,494 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $571.95 | 27 | $0 (2024) |
| Gilead Sciences, Inc. | $346.05 | 12 | $0 (2024) |
| Octapharma USA, Inc. | $145.50 | 3 | $0 (2024) |
| Theratechnologies Inc. | $134.69 | 6 | $0 (2024) |
| Insmed, Inc. | $93.33 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $71.28 | 5 | $0 (2023) |
| ABBVIE INC. | $70.14 | 4 | $0 (2024) |
| Melinta Therapeutics, LLC | $62.09 | 4 | $0 (2023) |
| TETRAPHASE PHARMACEUTICALS, INC. | $50.68 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $622.25 | 30 | ViiV Healthcare Company ($204.29) |
| 2023 | $850.14 | 40 | ViiV Healthcare Company ($477.39) |
| 2022 | $567.71 | 23 | ViiV Healthcare Company ($163.70) |
| 2021 | $280.45 | 11 | ViiV Healthcare Company ($190.04) |
| 2020 | $343.27 | 14 | ViiV Healthcare Company ($188.70) |
| 2019 | $552.86 | 17 | ViiV Healthcare Company ($269.44) |
| 2018 | $109.71 | 2 | Gilead Sciences, Inc. ($109.71) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.74 | General |
| 12/18/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: VIROLOGY | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: GI | ||||||
| 10/24/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: HIV | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/22/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/07/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: HIV | ||||||
| 09/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: VIROLOGY | ||||||
| 09/09/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: HIV | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/23/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: HIV | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: VIROLOGY | ||||||
| 06/12/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: BIOLOGIC | ||||||
| 06/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: HIV | ||||||
| 05/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: HIV | ||||||
| 04/26/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: HIV | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Infectious Diseases | ||||||
| 04/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: ANTIBIOTIC | ||||||
| 03/29/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: HIV | ||||||
| 03/18/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: HIV | ||||||
| 03/13/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Infections and Infectious Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 187 | 289 | $68,102 | $24,029 |
| 2022 | 4 | 262 | 557 | $108,464 | $37,852 |
| 2021 | 5 | 162 | 391 | $60,499 | $25,833 |
| 2020 | 4 | 192 | 522 | $72,101 | $36,232 |
Total Patients
803
Total Services
1,759
Medicare Billing
$123,945
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 124 | $24,800 | $10,674 | 43.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 52 | $20,020 | $6,524 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 100 | $19,876 | $5,607 | 28.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,406 | $1,224 | 35.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 73 | 214 | $42,586 | $14,443 | 33.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 97 | 249 | $34,362 | $12,738 | 37.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 56 | $21,560 | $7,204 | 33.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 37 | 38 | $9,956 | $3,466 | 34.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 281 | $33,412 | $14,947 | 44.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 47 | $8,627 | $3,604 | 41.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 34 | 35 | $7,190 | $3,534 | 49.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $5,930 | $2,378 | 40.1% |
| 36589 | Removal of central venous catheter for infusion | Office | 2021 | 12 | 12 | $5,340 | $1,370 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 93 | 318 | $34,980 | $17,383 | 49.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 39 | 143 | $22,451 | $11,237 | 50.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 25 | $7,425 | $3,854 | 51.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 36 | 36 | $7,245 | $3,758 | 51.9% |
About Dr. Kepler Davis, M.D
Dr. Kepler Davis, M.D is a Infectious Disease healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740357425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kepler Davis, M.D has received a total of $3,326 in payments from pharmaceutical and medical device companies, with $622.25 received in 2024. These payments were reported across 137 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,326).
As a Medicare-enrolled provider, Davis has provided services to 803 Medicare beneficiaries, totaling 1,759 services with total Medicare billing of $123,945. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Augusta, GA
- Active Since 11/29/2006
- Last Updated 09/10/2019
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1740357425
Products in Payments
- DOVATO (Drug) $761.10
- CABENUVA (Biological) $355.00
- PIFELTRO (Drug) $224.31
- PANZYGA (Biological) $167.09
- RUKOBIA (Drug) $154.94
- EGRIFTA (Drug) $134.69
- DIFICID (Drug) $126.47
- JULUCA (Drug) $124.99
- DELSTRIGO (Drug) $112.55
- Arikayce (Drug) $93.33
- Biktarvy (Drug) $84.24
- APRETUDE (Biological) $79.40
- ISENTRESS (Drug) $73.38
- SYMTUZA (Drug) $59.28
- MAVYRET (Drug) $54.36
- Fetroja (Drug) $47.18
- RUCONEST (Biological) $40.86
- Cresemba (Drug) $36.87
- XERAVA (Drug) $34.34
- Xerava (Drug) $33.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Augusta
Cheryl Newman, Md, MD
Infectious Disease — Payments: $150,138
Infectious Disease $150,138
John Rissing, Md, MD
Infectious Disease — Payments: $43,837
Infectious Disease $43,837
Dr. Jack Austin, Md, MD
Infectious Disease — Payments: $7,058
Infectious Disease $7,058
Dr. Francisco Hernandez Munoz, M.d, M.D
Infectious Disease — Payments: $4,252
Infectious Disease $4,252
Dr. Andrew Chao, M.d, M.D
Infectious Disease — Payments: $4,005
Infectious Disease $4,005
Jacobo Leon, Md, MD
Infectious Disease — Payments: $1,182
Infectious Disease $1,182